PUBLIC CONTRACT · 2019

61001819 - Medicamentos Usados Doenças Endocrinas_ SPMS

Contract value: €60,243.66
Signed on: 7 February 2019
Procedure: Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 5556555

PUBLISHED SUBJECT

ACARBOSE,50MG COMP BETAMETASONA 0,5 MG/ML SOL ORAL FR 30 ML,0,FR. BROMOCRIPTINA 2.5MG,COMP Deflazacorte 6 mg Comp DEFLAZACORT,30MG, COMP GLIBENCLAMIDA,5MG COMP GLICLAZIDA 80MG COMP GLUCAGOM (CLORIDRATO),1MG PÓ SOL INJ FR IM IV SC HIDROCORTISONA 100MG PÓ SOL INJ FR IM IV LEVOTIROXINA 100 MCG COMP METFORMINA 500 MG COMP METFORMINA 700 MG COMP METFORMINA 850 MG COMP METILPREDNISOLONA ,1000 MG, PÓ SOL INJ FR IM IV METILPREDNISOLONA ,125MG,PÓ SOL INJ FR IM IV Metilprednisolona 40 mg/1 ml Susp inj Fr 1 ml Intralesional IM ISsinovial Rectal METILPREDNISOLONA,16MG,COMP METILPREDNISOLONA,40MG,PÓ SOL INJ FR IM IV OXITOCINA,5U.I./1ML SOL INJ FR 1 ML IV PREDNISOLONA 20 MG COMP PREDNISOLONA 5 MG COMP TERLIPRESSINA (acetato) 0,2 MG/ML SOL INJ FR 5ML TIAMAZOL (Metibasol),5MG,COMP

Parties involved

Contracting body: Centro Hospitalar de Setúbal, E. P. E.
Awardee: LOGIFARMA - LOGISTICA FARMACÊUTICA S.A.; LABORATORIOS PFIZER, LDA; Merck, SA; MERCK SHARP & DHOME, LDA; Novo Nordisk - Comércio Produtos Farmacêuticos, Lda.; LABESFAL-LABORATORIOS ALMIRO,SA; SANOFI-PRODUTOS FARMACEUTICOS, LDA; MYLAN, LDA; HIKMA FARMACEUTICA PORTUGAL, SA; DLA; FRESENIUS KABI PHARMA PORTUGAL, LDA; GENERIS-FARMACEUTICA, SA
Place of performance: Portugal, Setúbal, Setúbal
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: LOGIFARMA - LOGISTICA FARMACÊUTICA S.A. · Tax ID 503934640
Awardee: LABORATORIOS PFIZER, LDA · Tax ID 500162166
Awardee: Merck, SA · Tax ID 500650870
Awardee: MERCK SHARP & DHOME, LDA · Tax ID 500191360
Awardee: Novo Nordisk - Comércio Produtos Farmacêuticos, Lda. · Tax ID 501485210
Awardee: LABESFAL-LABORATORIOS ALMIRO,SA · Tax ID 501169580
Awardee: SANOFI-PRODUTOS FARMACEUTICOS, LDA · Tax ID 500134960
Awardee: MYLAN, LDA · Tax ID 502248793
Awardee: HIKMA FARMACEUTICA PORTUGAL, SA · Tax ID 502266791
Awardee: DLA · Tax ID 503894427
Awardee: FRESENIUS KABI PHARMA PORTUGAL, LDA · Tax ID 504293753
Awardee: GENERIS-FARMACEUTICA, SA · Tax ID 508107997

Values and timeline

Contract price: €60,243.66
Procedure base price: €60,243.66
Total effective price: Not reported on Portal BASE
Publication date: 16 May 2019
Award date: 7 February 2019
Signing date: 7 February 2019
Performance period: 365 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion: Preço ou custo
CPV code: 33600000-6 - Produtos farmacêuticos
Legal basis: Artigo 259.º do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement: Hormonas e outros medicamentos usados no tratamento de doenças endócrinas
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 4034904

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts